Valuation : Amphastar Pharmaceuticals, Inc.

Market Cap 100.99Cr 87Cr 82Cr 75Cr 139.77Cr 9.54TCr 140.81Cr 971.62Cr 377.08Cr 4.88TCr 379.21Cr 370.92Cr 16TCr P/E 2026 *
10.9x
P/E 2027 * 8.99x
Enterprise Value 131.33Cr 113.3Cr 106.73Cr 97Cr 181.76Cr 12TCr 183.12Cr 1.26TCr 490.38Cr 6.34TCr 493.15Cr 482.37Cr 21TCr EV / Sales 2026 *
1.76x
EV / Sales 2027 * 1.52x
Free-Float
47.23%
Yield 2026 *
-
Yield 2027 * -
1 day+3.40%
1 week+7.81%
Current month+5.37%
1 month+19.06%
3 months+28.67%
6 months+12.99%
Current year-11.35%
1 week 21.52
Extreme 21.52
23.83
1 month 19.55
Extreme 19.55
23.83
Current year 16.64
Extreme 16.645
29.52
1 year 16.64
Extreme 16.645
29.78
3 years 16.64
Extreme 16.645
65.92
5 years 16.64
Extreme 16.645
67.66
10 years 12.05
Extreme 12.05
67.66
Manager TitleAgeSince
Chief Executive Officer 79 29/02/1996
Chief Operating Officer 76 29/02/1996
Director of Finance/CFO 58 01/04/2014
Director TitleAgeSince
Chairman 76 29/02/1996
Director/Board Member 79 29/02/1996
Director/Board Member 58 04/08/2022
Date Insider Type Main position Quantity % Market Cap. Importance
11/08/26 Sell

Director

-7,973 0.0181%
07/08/26 Exercice

Chief Financial Officer

18,286 0.0415%
09/07/26 Free

Director

24,532 0.0556%
Change 5-day change 1-year change 3-year change Capi.($)
+3.40%+7.81%-22.95%-56.46% 98Cr
+0.01%-2.47%+57.79%+108.23% 1,03400Cr
+1.48%+1.93%+54.56%+71.49% 65TCr
+0.67%-0.45%+23.50%+76.60% 46TCr
+0.49%-5.19%+33.28%+34.59% 34TCr
+0.27%+3.26%+29.76%+46.97% 31TCr
+0.12%-2.11%+0.60%+11.93% 25TCr
+1.08%+0.57%+54.34%+72.51% 24TCr
+2.64%-1.08%-15.85%-53.64% 20TCr
-0.21%+1.03%+32.74%+95.19% 19TCr
Average +0.99%-0.83%+24.78%+40.74% 36.73TCr
Weighted average by Cap. +0.63%-1.31%+38.84%+67.28%

Financials

2026 *2027 *
Net sales 75Cr 65Cr 61Cr 55Cr 103.49Cr 7.06TCr 104.27Cr 719.44Cr 279.21Cr 3.61TCr 280.79Cr 274.65Cr 12TCr 78Cr 68Cr 64Cr 58Cr 108.56Cr 7.41TCr 109.38Cr 754.71Cr 292.9Cr 3.79TCr 294.55Cr 288.11Cr 12TCr
Net income 9.93Cr 8.57Cr 8.07Cr 7.35Cr 14Cr 938.22Cr 14Cr 96Cr 37Cr 479.68Cr 37Cr 36Cr 1.58TCr 12Cr 9.96Cr 9.38Cr 8.55Cr 16Cr 1.09TCr 16Cr 111.05Cr 43Cr 557.45Cr 43Cr 42Cr 1.83TCr
Net Debt 30Cr 26Cr 25Cr 22Cr 42Cr 2.87TCr 42Cr 291.93Cr 113.3Cr 1.47TCr 113.94Cr 111.45Cr 4.81TCr 18Cr 16Cr 15Cr 14Cr 25Cr 1.74TCr 26Cr 177.17Cr 69Cr 889.33Cr 69Cr 68Cr 2.92TCr
Logo Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells active pharmaceutical ingredient (API) products. Most of the Company's finished products are contracted and distributed through group purchasing organizations, drug wholesalers, and drug retailers. The Company manufactures and sells over 25 prescription pharmaceutical products, and one over-the-counter product, Primatene MIST. Its marketed products include BAQSIMI (glucagon) nasal powder 3mg, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone, Cortrosyn, Amphadase, and Epinephrine injection. It manufactures and sells two API products: Recombinant Human Insulin (RHI API) and porcine insulin API. It is also focused on generic and proprietary product candidates in the injectable, inhalable, topical, and intranasal markets.
Employees
1,976
Date Price Change Volume
02/26/02 $23.74 +3.40% 4,36,695
01/26/01 $22.96 +1.91% 5,50,979
31/26/31 $22.53 +2.36% 2,74,025
28/26/28 $22.01 +0.59% 2,24,533
27/26/27 $21.88 -0.64% 2,59,787
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
23.74USD
Average target price
22.50USD
Spread / Average Target
-5.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMPH Stock